Swapnil Hanumant Phalle

Swapnil Hanumant Phalle

Director Director DIN 09502032
DIN 09502032 First appointment Feb 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Swapnil Hanumant Phalle

Data last updated:

Swapnil Hanumant Phalle has 4 years in corporate governance. Formerly with 1 company, such as Emp Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09502032
Primary Designation Director
First Appointment 11 Feb 2022
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emp Pharma Private Limited U24290PN2022PTC208512
Director11 Feb 20222022–Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Emp Pharma Private Limited
Premium access

Shareholding and investment profile for Swapnil Hanumant Phalle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swapnil Hanumant Phalle

Swapnil Hanumant Phalle has 4 years in corporate governance. Formerly with 1 company, such as Emp Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Swapnil Hanumant Phalle has expertise in General Business.

Swapnil Hanumant Phalle has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available